ARA - Milwaukee is a medicare approved dialysis facility center in Milwaukee, Wisconsin and it has 21 dialysis stations. It is located in Milwaukee county at Milwaukee Dialysis Center, Milwaukee, WI, 53209. You can reach out to the office of ARA - Milwaukee at (414) 265-1700. This dialysis clinic is managed and/or owned by American Renal Associates. ARA - Milwaukee has the following ownership type - Profit. It was first certified by medicare in December, 2005. The medicare id for this facility is 522565 and it accepts patients under medicare ESRD program.
| Name | ARA - Milwaukee |
|---|---|
| Location | Milwaukee Dialysis Center, Milwaukee, Wisconsin |
| No. of Dialysis Stations | 21 |
| Medicare ID | 522565 |
| Managed By | American Renal Associates |
| Ownership Type | Profit |
| Late Shifts | No |
| Milwaukee Dialysis Center, Milwaukee, Wisconsin, 53209 | |
| (414) 265-1700 | |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
| NPI Number | 1275644171 |
| Organization Name | Milwaukee Dialysis Center |
| Doing Business As | Ara-milwaukee Dialysis Llc |
| Address | 4775 N Green Bay Ave Milwaukee, Wisconsin, 53209 |
| Phone Number | (414) 265-1700 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 52 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 62 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 102 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 950 |
| Percentage of adult patients getting regular hemodialysis at the center | 95 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
| Adult patients getting regular peritoneal dialysis at the center | 9 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 67 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at ARA - Milwaukee with elevated calcium levels.
| Patients with hypercalcemia | 119 |
| Hypercalcemia patient months | 1116 |
| Patients with Serumphosphor | 119 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 29 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 26 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 10 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 63 |
| Patient months included in arterial venous fistula and catheter summaries | 629 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 48 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 17 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 94 |
| Hospitalization Rate in facility | 232.4 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 355.4 |
| Hospitalization Rate: Lower Confidence Limit | 155.5 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at ARA - Milwaukee were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 30 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 41.5 |
| Readmission Rate: Lower Confidence Limit | 19.9 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at ARA - Milwaukee get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .65 (As Expected) |
| SIR: Upper Confidence Limit | 1.35 |
| SIR: Lower Confidence Limit | .26 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether ARA - Milwaukee's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 75 |
| Transfusion Rate in facility | 68.3 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 147.6 |
| Transfusion Rate: Lower Confidence Limit | 34.7 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at ARA - Milwaukee lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 425 |
| Mortality Rate in facility | 12.1 (Better than Expected) |
| Mortality Rate: Upper Confidence Limit | 16.4 |
| Mortality Rate: Lower Confidence Limit | 8.7 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago
Davita - Wisconsin Ave Location: 3801 W Wisconsin Ave, Milwaukee, Wisconsin, 53208 Phone: (414) 937-8240 |
Fresenius Medical Care Midwest South Location: 3267 S 16th St Suite 203, Milwaukee, Wisconsin, 53215 Phone: (414) 672-8230 |
Davita - Rivercenter Dr Location: 117 N Jefferson St, Milwaukee, Wisconsin, 53202 Phone: (414) 225-3740 |
FMC Dialysis - Milwaukee Location: 161 W Wisconsin Ave, Milwaukee, Wisconsin, 53203 Phone: (414) 224-7666 |
Fresenius Medical Care Midwest Dialysis, Llc Location: 4021 N 52nd St, Milwaukee, Wisconsin, 53216 Phone: (414) 873-3600 |
News Archive
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Therapists, patients and families dealing with Borderline Personality Disorder now have an unprecedented guide to a way out of the misery and chaos in the form of the soon to be release book "Group Schema Therapy for Borderline Personality Disorder: Treatment Manual and Patient Workbook".
The National Reference Centre for Parasitology (NRCP), based at the MUHC, is developing a comprehensive and inexpensive blood safety test that will allow clinicians to check for all major parasitic diseases in patients' blood.
The latest research into schizophrenia and links between prenatal vitamin D and growth will be revealed at a public lecture at the Queensland Art Gallery, Australia next Friday (June 25).
An established second-line drug for chronic myelogenous leukemia has high response rates when given to newly diagnosed patients as their first therapy for the disease, according to early results from a Phase II clinical trial at The University of Texas M. D. Anderson Cancer Center.
› Verified 4 days ago